Michael Clayman

Michael Clayman

Président chez
Anokion SA
74 ans
Health Technology
Consumer Services
Industrial Services

Profil

Michael D.
Clayman
is the founder of Flexion Therapeutics, Inc., which was founded in 2007.
He held the title of President, Chief Executive Officer & Director from 2018 to 2021.
Currently, he is the Non-Executive Chairman at Anokion SA since 2016, Chairman at Ribometrix, Inc. since 2019, Chairman at Nido Biosciences, Inc. since 2022, and Director at Kanyos Bio, Inc. He previously worked as an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018.
He also held positions at Eli Lilly & Co., Abbott Cardiovascular Systems, Inc., Chorus Group Ltd., Lilly Research Laboratories, and Perelman School of Medicine.
He completed his undergraduate degree at Yale University and obtained a doctorate from UC San Diego School of Medicine.

Postes actifs de Michael Clayman

SociétésPosteDébut
Président 14/06/2018
Directeur/Membre du Conseil -
Président 27/09/2019
Président 01/08/2022

Anciens postes connus de Michael Clayman

SociétésPosteFin
FLEXION THERAPEUTICS, INC. Directeur Général 19/11/2021
AKEBIA THERAPEUTICS, INC. Directeur/Membre du Conseil 12/12/2018
Corporate Officer/Principal 01/01/2007
Conseiller Juridique Général -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Voir l'expérience en détail de Michael Clayman

Formation de Michael Clayman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Industrial Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Clayman
🔇